Latest Breaking News On - A major public health threat - Page 1 : comparemela.com

Antibody persistence of a single-doselive-attenuated chikungunya virus vaccine in adults. World Vaccine Congress, Washington 03-Apr-2024 .

District of columbiaUnited statesSouth africaSouth africanSusanne eder lingelbachInstituto butantanIndianj dermatolVp clinical developmentA major public health threatWorld vaccine congressCenters for diseaseHealth canadaDevelopment statusVaccine congressIntegrated expertiseLead phase